Medtronic

Companies Medtronic

News Medtronic

• David P. Lang Appointed Vice President of CryoLife International, Inc.

  CryoLife, Inc. announced that it has appointed David P. Lang as vice president of market development for CryoLife International Inc. In this newly created position, Mr. Lang will have responsibility for coordinating and developing the international marketing and distribution strategies for PerClot, more

• CollPlant developing Type I Recombinant Human Collagen from Transgenic Tobacco Plants

  CollPlant Ltd., a biotechnology company specializing in the development and commercialization of novel medical products based on its plant-derived, Type I collagen and other recombinant proteins, announced that they elected Mr. Ronny Barak as Chief Executive Officer and Director of CollPlant. Mr. more

• Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases

  Medtronic, Inc. and Alnylam Pharmaceuticals, Inc. announced that the companies are advancing their collaboration initiated in February, 2005, following positive pre-clinical data generated under the initial joint technology development phase of the program. Under the terms of the agreement, Alnylam more

White papers Medtronic

• Outsourcing R&D Innovation takes on New Meaning
  

  Innovative drugs are the lifeblood of pharmaceutical companies, but the cost of developing them is rising to unsustainable levels. Pharma executives are already saying that as the economy falters, they foresee bleak prospects and mergers unless their companies get more innovative drugs into their pipelines. The clock is ticking on the race to increase productivity, as key patents worth a projected $30 billion in revenue will expire between 2010 and 2013, opening the floodgates to competition from generics, according to Barbara Ryan, an analyst at Deutsche Bank. This imperative is propelling increased outsourcing of R&D operations as companies trim overcapacity. more

Publications Medtronic

• A year in the life of a cardiologist: an interview with Dr Ganesh Manoharan

  Interview by Louise Rishton (Commissioning Editor) and Tanya Stezhka (Assistant Commissioning Editor) Ganesh Manoharan graduated with Distinction from Queens University of Belfast (UK) in 1993. He completed his training in Cardiology in Belfast and his Advanced Interventional Cardiology Fellowship a more

• Pulmonary vein intramural hematoma as a complication of cryoballoon ablation of paroxysmal atrial fibrillation

  Abstract A 45‐year‐old man was referred to our department for cryoballoon (CB) ablation of symptomatic drug‐resistant paroxysmal atrial fibrillation (AF). The procedure was performed with a single uneventful transatrial access. A 20 mm‐diameter Achieve (AC) inner lumen mapping catheter was place more

• CoreValve® transcatheter self-expandable aortic bioprosthesis

  Transcatheter aortic valve implantation has been designed to treat patients affected by severe symptomatic aortic stenosis considered extremely high risk for surgical aortic valve replacement. The CoreValve® (Medtronic Inc., MN, USA) is a multilevel self-expanding and fully radiopaque nitinol frame more

Market studies Medtronic

• Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

  Introduction GlobalData’s new report, “Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the Austria Neurology Devices market. The report provides value (USD million), vol more

• Stent Grafts Market in China 2011-2015

  TechNavio’s analysts forecast the Stent Grafts market in China to grow at a CAGR of 18 percent over the period 2011–2015. One of the key factors contributing to this market growth is the advancements in endovascular aneurysm repair (EVAR) worldwide. The Stent Grafts market in China has also been wit more

• Global Continuous Glucose Monitoring Device Market 2011-2015

  TechNavio’s analysts forecast the the Global Continuous Glucose Monitoring Device market to grow at a CAGR of 11.5 percent over the period 2011–2015. One of the key factors contributing to this market growth is worldwide rise in diabetic population. The Global Continuous Glucose Monitoring Device ma more

Websites Medtronic